Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Surg Res. 2018 Oct 23;234:294–302. doi: 10.1016/j.jss.2018.08.048

Figure 5: GYY4137 reduces intestinal injury in WT animals treated with GYY4137 after I/R, but does not affect injury in eNOSKO animals.

Figure 5:

A) Histologic injury scores were significantly improved in the WT I/R group treated with GYY4137, but no similar effect was noted in eNOSKO animals (*: p<0.05 vs. vehicle group). B) Representative histology sections of the 4 groups, demonstrating very deranged villous architecture in both vehicle groups and the eNOSKO group treated with GYY4137. Only the WT animals treated with GYY4137 retain a semblance of normal bowel structure.